Cas:10374-74-0 7-Tetradecene manufacturer & supplier

Chemical Name:7-Tetradecene

CAS.NO:10374-74-0

Synonyms:EINECS 233-815-7;tetradec-7-ene;7-tetradecene

Molecular Formula:C₁₄H₂₈

Molecular Weight:196.37200

HS Code:2901299090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:250ºC(lit.)

Density:0.764 g/mL at 25ºC(lit.)

Index of Refraction:n20/D 1.438

PSA:

Exact Mass:196.21900

LogP:5.48340

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like EINECS 233-815-7 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,7-tetradecene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 233-815-7 Use and application,EINECS 233-815-7 technical grade,usp/ep/jp grade.

Related News: Over the duration of this study, investigators observed a 4.2% reduction in annualised absolute risk of cardiovascular death or heart failure hospitalisations compared to placebo. 6-chloro-2-(methylthio)-3-(1-(naphthalen-2-yl)ethyl)thieno[2,3-d]pyrimidin-4(3H)-one manufacturers This commitment to global expansion comes off the heels of surpassing $100 million in annual recurring revenue. BetterUp more than doubled its revenue this year, recorded a net revenue retention rate of over 170 percent, grew its entire customer base by over 80 percent, and more than doubled coaching sessions year-over-year. 2-[4-(3-Chloro-phenyl)-piperazin-1-ylmethyl]-1-methyl-1H-benzoimidazole suppliers TULIP-2 assessed the effect of anifrolumab in reducing disease activity as measured by the BILAG-Based Composite Lupus Assessment (BICLA) scale. In TULIP-1, 457 eligible patients were randomised (1:2:2) and received a fixed-dose intravenous infusion of 150mg anifrolumab, 300mg anifrolumab or placebo every four weeks, Benzyl-((3aR,7aR)-1,3-dimethyl-2-oxo-octahydro-2λ5-benzo[1,3,2]diazaphosphol-2-yl)-methyl-amine vendor & factory.